Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Thoracic 1 NET 1 Endocrine 1 Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 29 Carcinoma, Renal Cell 8 Urinary Bladder Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasms 6 Melanoma 6 Small Cell Lung Carcinoma 5 Ovarian Neoplasms 5 Carcinoma, Transitional Cell 5 Carcinoma, Merkel Cell 5 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Breast Neoplasms 4 Neoplasm Metastasis 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Mesothelioma, Malignant 2 Head and Neck Neoplasms 2 Uveal Melanoma 1 Turcot syndrome 1 Thymoma 1 Sarcoma 1 Recurrence 1 Primary Myelofibrosis 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Microsatellite Instability 1 Mesothelioma 1

Interventions

Carboplatin 24 Pemetrexed 18 Cisplatin 17 Paclitaxel 14 pembrolizumab 13 Gemcitabine 8 osimertinib 7 durvalumab 6 Docetaxel 6 Nivolumab 5 Erlotinib Hydrochloride 5 130-nm albumin-bound paclitaxel 5 capmatinib 3 brigatinib 3 anlotinib 3 Gefitinib 3 Drug Therapy 3 vosaroxin 2 volociximab 2 sintilimab 2 pralsetinib 2 ensartinib 2 atezolizumab 2 aflibercept 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiation 2 Oncolytic Virotherapy 2 Ipilimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × avelumab × Thoracic × Clear all

NCT03268057 2022-05-02

CLASSICAL-Lung

Vaccinex Inc.

Phase 1/2 Completed

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡